Second-line chemotherapy in advanced biliary cancer progressed to first-line platinum-gemcitabine combination: a multicenter survey and pooled analysis with published data

BACKGROUND: After progression to a standard first-line platinum and gemcitabine combination (GP), there is no established second-line therapy for patients with advanced biliary tract cancers (aBTC). Indeed, literature data suggest limited activity of most second-line agents evaluated so far. METHODS...

Descripción completa

Detalles Bibliográficos
Autores principales: Fornaro, Lorenzo, Vivaldi, Caterina, Cereda, Stefano, Leone, Francesco, Aprile, Giuseppe, Lonardi, Sara, Silvestris, Nicola, Santini, Daniele, Milella, Michele, Caparello, Chiara, Musettini, Gianna, Pasquini, Giulia, Falcone, Alfredo, Brandi, Giovanni, Sperduti, Isabella, Vasile, Enrico
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2015
Materias:
Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4689003/
https://www.ncbi.nlm.nih.gov/pubmed/26693938
http://dx.doi.org/10.1186/s13046-015-0267-x

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4689003/
https://www.ncbi.nlm.nih.gov/pubmed/26693938
http://dx.doi.org/10.1186/s13046-015-0267-x

Ejemplares similares